Safety and efficacy of oral chemokine receptor 2 antagonist CCX140-B in a phase 2 type 2 diabetes studyM. Hanefeld, E. Schell,I. Gouni-Berthold, M. Melichar, I. Vesela,T. Sullivan,S. Miao,D. Johnson, J. C. Jaen, T. J. Schall, P. BekkerDIABETOLOGIA（2011）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
